Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-02-03 @ 8:50 AM
Study NCT ID:
NCT01125293
Status:
TERMINATED
Last Update Posted:
2021-04-23
First Post:
2010-03-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Sponsor:
Organization: